Return to Today's science sparks archives

2006-07-06

Collaboration between

Collaboration between
  • Bai F, Pei XH, Pandolfi PP, Xiong Y

  • Mol Cell Biol. 2006 Jun;26(12):4564-76

2006-07-07

Genetic analysis of the interface between Ubc9 and RanGAP1

Genetic analysis of the interface between Ubc9 and RanGAP1
  • Yunus AA, Lima CD

  • Nat Struct Mol Biol. 2006 Jun;13(6):491-9. Epub 2006 May 28.

2006-07-11

PHD Finger Grips Histone Tails

PHD Finger Grips Histone Tails
  • Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, Patel DJ

  • Nature. 2006 Jul 6;442(7098):91-5. Epub 2006 May 21.

2006-07-13

Figure 2

Figure 2
  • Seetharaman J, Rajashankar KR, Solorzano V, Kniewel R, Lima CD, Bonanno JB, Burley SK, Swaminathan S.

  • Proteins. 2006 Jun 1;63(4):1092-6.

2006-07-17

MRI data: structural images, FA maps, and fiber reconstruction.

MRI data: structural images, FA maps, and fiber reconstruction.
  • Voss HU, Uluc AM, Dyke JP, Watts R, Kobylarz EJ, McCandliss BD, Heier LA, Beattie BJ, Hamacher KA, Vallabhajosula S, Goldsmith SJ, Ballon D, Giacino JT, Schiff ND.

  • J Clin Invest. 2006 Jul 3;116(7):2005-2011.

2006-07-18

Fig 2. Case 2. A, Agminated melanocytic nevi seen on midlower aspect of patient's back. B, Dermoscopic image showing patchy reticulated network.

Fig 2. Case 2. A, Agminated melanocytic nevi seen on midlower aspect of patient's back. B, Dermoscopic image showing patchy reticulated network.
  • Bragg JW, Swindle L, Halpern AC, Marghoob AA.

  • J Am Acad Dermatol. 2005 Jan;52(1):67-73.

2006-07-19

Figure 3. Defects in Mesoderm Development and Migration in p38IP

Figure 3. Defects in Mesoderm Development and Migration in p38IP
  • Zohn IE, Li Y, Skolnik EY, Anderson KV, Han J, Niswander L

  • Cell. 2006 Jun 2;125(5):957-69.

2006-07-21


  • Serganov A, Polonskaia A, Phan AT, Breaker RR, Patel DJ

  • Nature. 2006 Jun 29;441(7097):1167-71. Epub 2006 May 21.

2006-07-24

Fig. 1. Joseph H. Burchenal

Fig. 1. Joseph H. Burchenal
  • Varmus H

  • Science. 2006 May 26;312(5777):1162-5.

2006-07-26

Photomicrographs of Case 1.

Photomicrographs of Case 1.
  • Puri DR, Meyers PA, Kraus DH, Laquaglia MP, Wexler LH, Wolden SL

  • Pediatr Blood Cancer. 2006 Jul 19; [Epub ahead of print]

2006-07-30

Metallophosphoesterase active site.

Metallophosphoesterase active site.
  • Keppetipola N, Shuman S

  • J Biol Chem. 2006 Jul 14;281(28):19251-9. Epub 2006 May 4.

2006-08-09

Fig 3.

Fig 3.
  • Agero AL, Busam KJ, Benvenuto-Andrade C, Scope A, Gill M, Marghoob AA, Gonzalez S, Halpern AC

  • J Am Acad Dermatol. 2006 Apr;54(4):638-43.

2006-08-15

Figure 1. Characterization of Metastatic Escapers

Figure 1. Characterization of Metastatic Escapers
  • Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, Flotte TJ, Duncan LM, Granter SR, Chin L

  • Cell. 2006 Jun 30;125(7):1269-81.

2006-08-23

FIG. 2. GFP reporter expression in BAC-Kit-GFP transgenic mice.

FIG. 2. GFP reporter expression in BAC-Kit-GFP transgenic mice.
  • Berrozpe G, Agosti V, Tucker C, Blanpain C, Manova K, Besmer P

  • Mol Cell Biol. 2006 Aug;26(15):5850-60.

2006-08-29

Figure 6. PGE2 produced by tumor cells stimulates CYP19 gene expression in breast adipose stromal and tumor cells.

Figure 6. PGE2 produced by tumor cells stimulates CYP19 gene expression in breast adipose stromal and tumor cells.
  • Subbaramaiah K, Howe LR, Port ER, Brogi E, Fishman J, Liu CH, Hla T, Hudis C, Dannenberg AJ

  • Cancer Res. 2006 May 15;66(10):5504-11.

2006-09-07

Figure 1. The self-seeding concept of cancer growth and metastasis.

Figure 1. The self-seeding concept of cancer growth and metastasis.
  • Norton L, Massague J

  • Nat Med. 2006 Aug;12(8):875-8.

2006-09-13

 Figure 6. Extent of cellular resistance for mutations identified within the Bcr-Abl kinase domain to imatinib and PD166326.

Figure 6. Extent of cellular resistance for mutations identified within the Bcr-Abl kinase domain to imatinib and PD166326.
  • von Bubnoff N, Veach DR, van der Kuip H, Aulitzky WE, Sanger J, Seipel P, Bornmann WG, Peschel C, Clarkson B, Duyster J

  • Blood 2005 Feb 15;105(4):1652-9.

2006-09-15

FIGURE 1. The triphosphate tunnel fold of yeast Cet1 is recapitulated in archaeal and bacterial homologs.

FIGURE 1. The triphosphate tunnel fold of yeast Cet1 is recapitulated in archaeal and bacterial homologs.
  • Chunling Gong, Paul Smith and Stewart Shuman

  • RNA. 2006 Aug;12(8):1468-74. Epub 2006 Jun 29.

2006-09-18

 Figure 1. Follicular lymphoma: mixed population of centrocytes and centroblast (arrow).

Figure 1. Follicular lymphoma: mixed population of centrocytes and centroblast (arrow).
  • Brandao GD, Rose R, McKenzie S, Maslak P, Lin O

  • Cancer Cytopathology. 2006 Aug 25; [Epub ahead of print]

2006-09-20

 Fig. 1. Recurrent ovarian adult granulosa cell tumors involving abdominal precaval lymph nodes (blue arrow). White arrow demonstrates right ureter.

Fig. 1. Recurrent ovarian adult granulosa cell tumors involving abdominal precaval lymph nodes (blue arrow). White arrow demonstrates right ureter.
  • Abu-Rustum NR, Restivo A, Ivy J, Soslow R, Sabbatini P, Sonoda Y, Barakat RR, Chi DS

  • Gynecologic Oncology.Volume 103, Issue 1, October 2006, Pages 31-34

2006-09-21

 Fig. 1   Schematic diagram of the isolated limb infusion circuit.

Fig. 1 Schematic diagram of the isolated limb infusion circuit.
  • Brady MS, Brown K, Patel A, Fisher C, Marx W

  • Ann Surg Oncol.2006 Aug;13(8):1123-9. Epub 2006 Jun 21

2006-09-25

 Figure 4. Effects of lysinated-betulonic acid at a concentration of 5.5 ◊ 10-4 M on ex vivo tumor tissues.

Figure 4. Effects of lysinated-betulonic acid at a concentration of 5.5 ◊ 10-4 M on ex vivo tumor tissues.
  • Saxena BB, Zhu L, Hao M, Kisilis E, Katdare M, Oktem O, Bomshteyn A, Rathnam P

  • Bioorg Med Chem. 2006 Sep 15;14(18):6349-58. Epub 2006 Jun 13.

2006-09-26

 Fig. 1. Max Nitze (1848 to 1906)

Fig. 1. Max Nitze (1848 to 1906)
  • Herr, HW

  • J Urol.2006 Oct;176(4 Pt 1):1313-6.

2006-09-27

 Fig. 10. (a) Axial sections from the kV planning CT (left) and MV CBCT (right) of a patient with nonsmall cell lung carcinoma.

Fig. 10. (a) Axial sections from the kV planning CT (left) and MV CBCT (right) of a patient with nonsmall cell lung carcinoma.
  • Sillanpaa J, Chang J, Mageras G, Yorke E, De Arruda F, Rosenzweig KE, Munro P, Seppi E, Pavkovich J, Amols H

  • Medical Physics.2006;33(9):3489-97.

2006-09-28

 FIGURE 4.  FP PET/CT in 50-y-old man with cancer of right oral tongue.

FIGURE 4. FP PET/CT in 50-y-old man with cancer of right oral tongue.
  • Schoder H, Carlson DL, Kraus DH, Stambuk HE, Gonen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ

  • J Nucl Med.2006 May;47(5):755-62.

2006-09-29

Figure 2 Pml loss leads to an increase in pAkt in vivo.

Figure 2 Pml loss leads to an increase in pAkt in vivo.
  • Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP

  • Nature.2006 May 25;441(7092):523-7. Epub 2006 May 7.